Last reviewed · How we verify
NCT03483597
The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis
trial testing TSQM-II in Rheumatoid Arthritis in 1,365 participants. Completed in 30 April 2018.
30 April 2018
Quick facts
| Lead sponsor | Chinese SLE Treatment And Research Group |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,365 |
| Start date | 31 March 2018 |
| Primary completion | 30 April 2018 |
| Estimated completion | 30 April 2018 |
| Sites | 1 location across China |
Drugs / interventions tested
- TSQM-II
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Satisfaction — all drugs for Satisfaction →
Sponsor
Chinese SLE Treatment And Research Group
Who can join
18 and older, any sex, with Rheumatoid Arthritis or Satisfaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A questionnaire for this research is designed, which initiated from TSQM-II treatment satisfaction questionnaire and based on research launched by rheumatology and immunology departments of Chinese 12 public tertiary hospitals distributed directionally by Chinese Rheumatism Data Center (CRDC). The research is about treatment satisfaction and its influencing factors for Chinese rheumatoid immunologists and rheumatoid arthritis (RA) patients as well as their expectations for treating this disease. This research will explore the matching degree between treatment satisfaction and expectation about rheumatoid arthritis from doctors and patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.
Jiang N, Yang P, Liu S, Li H, et al · · 2020 · cited 10× · PMID 32606620 · DOI 10.2147/ppa.s232578
Verify or expand the search:
- PubMed search for NCT03483597
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Chinese SLE Treatment And Research Group trials
Trials by the same sponsor.
- NCT07381465 — Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus · Phase 4 · not yet recruiting
- NCT07451665 — Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis · Phase 4 · not yet recruiting
- NCT07013838 — The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis · Phase 4 · not yet recruiting
- NCT06881290 — Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus · Phase 1 · recruiting
- NCT06887517 — Chinese Rheumatism Biobank(CRB) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03483597 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chinese SLE Treatment And Research Group
- Last refreshed: 31 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03483597.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing